C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/21/2002	WO2002042468A3 Glycosyltransferase vectors for treating cancer
11/21/2002	WO2002036076A3 Cell lines expressing a mch receptor
11/21/2002	WO2002031201A3 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002	US20020174455 Sustained totipotent culture of selected monocot genera
11/21/2002	US20020173806 Method for autologous transplantation
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173463 Isolated nucleic acids; and antibodies
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173459 Isolated peptide; antibodies; genetic engineering
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173454 Nucleic acids, proteins, and antibodies
11/21/2002	US20020173448 Method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
11/21/2002	US20020173039 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/21/2002	US20020173037 Efficient method of protoplast culture
11/21/2002	US20020173036 Cell line and method of making and using same
11/21/2002	US20020173033 Device and method or three-dimensional spatial localization and functional interconnection of different types of cells
11/21/2002	US20020173030 Lenitiviral packaging system for use as tool in genetic engineering
11/21/2002	US20020173029 Chemical structure for use in the prevention and treatment of viral infections
11/21/2002	US20020173019 Enzymes for biopolymer production
11/21/2002	US20020173018 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172982 Glycoprotein for use in diagnosis and treatment of human sexual disorders
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172940 Methods and reagents for isolating biologically active peptides
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172935 Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors
11/21/2002	US20020172934 Gel nutrient for use in storage and preservation of tissues
11/21/2002	US20020172705 Bioengineered tissue constructs and methods for producing and using thereof
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172670 Used to generate models for elucidating the structure of other polypeptides and for better identifying ligands capable of modulating mannosidase II activity
11/21/2002	US20020172665 May be transplanted to reverse hyperglycemia
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	DE10106826C1 Medium zur Züchtung von Tumorzellen Medium for the growth of tumor cells
11/21/2002	CA2713200A1 Serine o-acetyl transferase
11/21/2002	CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	CA2447343A1 Method to induce neovascular formation and tissue regeneration
11/21/2002	CA2447139A1 Specific binding proteins and uses thereof
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2447015A1 Insulin producing cells derived from human embryonic stem cells
11/21/2002	CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002	CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002	CA2446606A1 Inhibitors of dna methyltransferase isoforms
11/21/2002	CA2446180A1 Cytokine polypeptides
11/21/2002	CA2446131A1 Composition and method for increasing cell density in cell cultures infected with lentivirus
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2442635A1 Gastrokines and derived peptides including inhibitors
11/21/2002	CA2442144A1 A helper dependent adenoviral vector system and methods for using the same
11/21/2002	CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002	EP1258729A2 A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
11/20/2002	EP1258531A1 Compounds and methods for inhibiting axillary malodour
11/20/2002	EP1258530A2 Gaba-A receptor subunits (alpha-2, alpha-3, alpha-5, alpha -6, beta-2) and transfected cells expressing them
11/20/2002	EP1258529A2 FLIP Gene and FLIP Protein
11/20/2002	EP1257822A1 Her-2 binding antagonists
11/20/2002	EP1257671A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
11/20/2002	EP1257669A1 Antisense modulation of e2f transcription factor 3 expression
11/20/2002	EP1257657A2 Autoregulatory expression vector for gene therapy
11/20/2002	EP1257656A2 Recombinant aav packaging systems
11/20/2002	EP1257653A2 Phosphodiesterase type 7b
11/20/2002	EP1257650A1 Polymerase compositions and methods of use thereof
11/20/2002	EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/20/2002	EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257643A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same
11/20/2002	EP1257639A2 Nucleozymes with endonuclease activity
11/20/2002	EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002	EP1257634A2 Method of making embryoid bodies from primate embryonic stem cells
11/20/2002	EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
11/20/2002	EP1257632A1 Simultaneous stimulation and concentration of cells
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257584A2 Humanized antibodies that sequester amyloid beta peptide
11/20/2002	EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257573A2 New transcription factor carp-2
11/20/2002	EP1257566A1 Method of treating disorders of the eye
11/20/2002	EP1257561A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257559A1 Mammalian sphingosine-1-phosphate phosphatase
11/20/2002	EP1257295A2 Factor vii or viia-like molecules
11/20/2002	EP1257290A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries

1 ... 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 ... 1827